1993

BACCI G., BRICCOLI A., FERRARI S., RUGGIERI P., AVELLA M., CASADEI R., BATTISTINI A., PICCI P.
“Osteosarcoma of the extremities metastatic at presentation. Results obtained with primary chemotherapy followed by simultaneous resection of the primary and metastatic lesion”
“Osteosarcoma delle estremita’ con metastasi all’esordio: risultati ottenuti con chemioterapia primaria seguita dall’intervento chirurgico contemporaneo sulla lesione primitiva e metastatica.”
Min. Chir., 48, 35-45

CASADEI R., RUGGIERI P., BORIANI S.
“Valutazione del rischio di frattura patologica nel paziente metastatico.”
Atti 107° S.E.R.T.O.T., XXXV, 157-166

CASADEI R., ANDREOLI I., DE IURE F., DE CRISTOFARO R., FERRUZZI A., BIAGINI R., RUGGIERI P.:
“Trattamento chirurgico delle fratture patologiche dell’arto inferiore in meta da carcinoma.”
Atti 107° S.E.R.T.O.T., XXXV, 139-155

BUNGARO P., RUGGIERI P., PAVONE S., VENDEMIA V.
“The Tour Eiffel double Rush nail in the treatment of fractures of the lower limb.”
Chir. Org. Mov., 78(1), 25-29

RUGGIERI P., BIAGINI R., BACCI G., FERRARO A., FERRUZZI A., DE CRISTOFARO R., MERCURI M., PICCI P., CAPANNA R., CAMPANACCI M
Surgery of osteosarcoma of the extremities: indications and complications in the recent experience at the Istituto Ortopedico Rizzoli
Cancer treatment and research, vol.62,185-203
BERTONI F., BACCHINI P., CAPANNA R., RUGGIERI P., BIAGINI R., FERRUZZI A., BETTELLI G., PICCI P., CAMPANACCI M.
“Solid variant of aneurysmal bone cyst.”
Cancer, 71, N°. 3, 729-734

PICCI P., ROUGRAFF B.T., BACCI G., NEFF J.R., SANGIORGI L., CAZZOLA A., BALDINI N., FERRARI S., MERCURI M., RUGGIERI P., CALDORA P., BENASSI M.S., FABBRI N., MONTI C., CAMPANACCI M.
“Prognostic significance of histopatological response to chemotherapy in non-metastatic Ewing’s sarcoma of the extremities.”
J. Clin. Oncol. 11, 1763-1769

BACCI G., PICCI P., FERRARI S., RUGGIERI P., CASADEI R., TIENGHI A., BRACH DEL PREVER A., GHERLINZONI F., MERCURI M., MONTI C.
“Primary chemotherapy and delayed surgery for non-metastatic osteosarcoma of the extremities followed by Cisplatin and Doxorubicin.”
Cancer 72, 3227-3238

BERTONI F., BACCHINI P., FABBRI N., MERCURI M., PICCI P., RUGGIERI P., CAMPANACCI M.
“Osteosarcoma: low grade intraosseous-type osteosarcoma, histologically resembling parosteal osteosarcoma, fibrous dysplasia, and desmoplastic fibroma.”
Cancer, Vol.71, N°2, 338-345

BACCI G., PICCI P., RUGGIERI P., FERRARI S., MERCURI M., FABBRI N., ROSITO P., BARBIERI E., FERRARO A., CASADEI R., BRACH DEL PREVER A., TIENGHI A., CAZZOLA A., CAMPANACCI M.
“No advantages in the addition of Ifosfamide and VP-16 to the standard four-drug regimen in the manteinance phase of neoadjuvant chemotherapy of Ewing’s sarcoma of bone: results of two sequential study.”
J. Chemotherapy, 5, 247-257

RUGGIERI P., SIM F.H., BOND J.R., UNNI K.K.
“Malignancies in fibrous dysplasia.”
Laboratory investigation, vol.68, p.A10.

CASADEI R., DE IURE F., ANDREOLI I., FABBRI N., FERRARO A., BIAGINI R., RUGGIERI P.:
“Fratture patologiche dell’omero nel paziente metastatico.”
Atti 107° S.E.R.T.O.T., XXXV, 29-37

RUGGIERI P., DE CRISTOFARO R., PICCI P., BACCI G., BIAGINI R., CASADEI R., FERRARO A., FERRUZZI A., FABBRI N., CAZZOLA A., CAMPANACCI M.
“Complications and surgical indications in 144 cases of nonmetastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy.”
Clinical Orthopaedics and Related Research, 295, 226-238

BACCI G, PICCI P, FERRARI S., ORLANDI M., RUGGIERI P., AVELLA M., CASADEI R., FERRARO A., BIAGINI R., BATTISTINI A.
“Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy.”
Cancer, 71, 1224-1230